This brand name is authorized in Cyprus, Hong Kong, Malta, Singapore
The drug ALFOXAN contains one active pharmaceutical ingredient (API):
1
Mefenamic acid
UNII 367589PJ2C - MEFENAMIC ACID
|
Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
ALFOXAN Film-coated tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
ALFOXAN Hard capsule | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
M01AG01 | Mefenamic acid | M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AG Fenamates |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: HK | Department of Health Drug Office | Identifier(s): 66854 |
Country: MT | Medicines Authority | Identifier(s): MA084/03101, MA084/03102 |
Country: SG | Health Sciences Authority | Identifier(s): 08162P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.